- Prevents the development of immune mediated liver fibrosis by inhibiting the expression of collagen & other matrix components
- Shows beneficial effects in weight reduction, produces improvements in biochemical & imaging markers of liver disease
- Safe & effective in cholestasis of pregnancy, attenuate pruritis & corrects biochemical abnormalities in the mother
- Ciprofloxacin & Ursodeoxycholic acid shows a synergistic effect on prevention of bacterial translocation in obstructive jaundice
Brand Name: Takeliv-300,GSD-500
Indication: Radiolucent,Non-Calcified Gall Stones,Cholestatic Liver Diseases/Cholestasis of Pregnancy,Non-Alcoholic fatty liver,Hepatitis,Obstructive jaundice
Dosage:
- 10-20 mg / kg day in 2-4 divided dose